News

Adopting a healthier lifestyle is more effective than using the anti-diabetes drug metformin, with the benefits persisting ...
A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...
The obesity drug liraglutide cut migraine days in half in a small trial, though more research is needed to exclude the ...
GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...
In a small cell therapy trial, 10 out of 12 people with type 1 diabetes no longer needed supplemental insulin, even a year after treatment.
Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...
A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction ...
A novel medication out of Sweden has shown some of the same promise in melting belly fat — without making your stomach churn.
This discovery could make treatment for an eye disease affecting millions with diabetes more accessible and affordable.
A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction ...
A diabetes medication that lowers brain fluid pressure has cut monthly migraine days by more than half, according to a new ...
A new oral drug mimics exercise, burns fat, lowers blood sugar, and preserves muscle mass, potentially outperforming Ozempic ...